Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 5Polycystic Ovary Syndrome 3Neoplasms 3Prostatic Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Wilms Tumor 1Venous Thromboembolism 1Tuberous Sclerosis 1Thrombosis 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Perioperative Inflammatory Response 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1Margins of Excision 1Lymphangioleiomyomatosis 1

Interventions

Simvastatin 1Danazol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Long Qt Syndrome 3 × Simvastatin × Clear all
NCT00575601 2009-07-02

Effects of Simvastatin on Biochemical Parameters and Outcome of IVF-ICSI in Pcos Patients

Tehran University of Medical Sciences

Phase 3 Completed
120 enrolled

Long Qt Syndrome 3, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡